Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-23-004066
Filing Date
2023-06-12
Accepted
2023-06-12 11:25:47
Documents
73
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 aclarion_i10ka-123122.htm   iXBRL 10-K/A 2143075
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM aclarion_ex2301.htm EX-23.1 3048
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM aclarion_ex2302.htm EX-23.2 2334
4 CERTIFICATION aclarion_ex3101.htm EX-31.1 10075
5 CERTIFICATION aclarion_ex3102.htm EX-31.2 10127
6 CERTIFICATION aclarion_ex3201.htm EX-32.1 3956
7 CERTIFICATION aclarion_ex3202.htm EX-32.2 3976
  Complete submission text file 0001683168-23-004066.txt   8163155

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE acon-20221231.xsd EX-101.SCH 51926
9 XBRL CALCULATION FILE acon-20221231_cal.xml EX-101.CAL 52261
10 XBRL DEFINITION FILE acon-20221231_def.xml EX-101.DEF 255968
11 XBRL LABEL FILE acon-20221231_lab.xml EX-101.LAB 360394
12 XBRL PRESENTATION FILE acon-20221231_pre.xml EX-101.PRE 334812
67 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_i10ka-123122_htm.xml XML 1345736
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41358 | Film No.: 231007402
SIC: 8071 Services-Medical Laboratories